authors

• Richter, Michael D
• Hughes, Grant C
• Chung, Sarah H
• Ezeanuna, Mary
• Namrata Singh, MD MSCI
• Thompson, John A

publication date

• January 1, 2020

published in

• Best practice & research. Clinical rheumatology  Journal

has subject area

• Humans
• Immunotherapy
• Neoplasms
• T-Lymphocytes

Keywords

• CTLA-4
• Checkpoint inhibitor
• Immune-related adverse event
• Immunotherapy
• PD-1

Digital Object Identifier (DOI)

• https://doi.org/10.1016/j.berh.2020.101511

PubMed ID

• 32299675

start page

end page

volume

• 34

issue

• 4